Table 2 Incidence rate of MSI and LOH, number of alleles isolated, and allelic imbalance noticed for each marker
Marker | Chr./Locus | No of positive patients | % of positive MSI | No. of alleles isolated | Allelic imbalance |
|---|---|---|---|---|---|
Mfd15 | 17q11.2 | 15 | 19.2% | 7 | L 0–0.69 U 1.56-2.72 |
APC | 5q21/22 | 17 | 21.8% | 8 | L 0–0.69 U 1.5-2.61 |
Tp53-Alu | 17p13.1 | 27 | 34.6% | 12 | L 0–0.67 U 1.48-2.53 |
Mfd41 | 17p12-11.1 | 21 | 26.9% | 8 | L 0–0.59 U 1.35-2.76 |
Bat-25 | 4q12 | 0 | 0% | 4 | L 0.71-0.77 U 0.94-1.2 |
TP53.PCR15 | 17p13.1 | 0 | 0% | 5 | L 0.80-0.86 U 0.92-1.23 |
AFM093xh3 | 2p16 | 11 | 14.1% | 6 | L 0–0.68 U 1.51-2.44 |
Bat-40 | 1p13.1 | 0 | 0% | 4 | L 0.73-0.81 U 0.91-1.31 |
Bat-26 | 2p | 3 | 3.8% | 4 | L 0.23-0.62 U 1.31-1.65 |
Mfd28 | 10pter | 7 | 8.9% | 5 | L 0.2-0.64 U 1.37-1.95 |